Fortrea Holdings Inc. ( ($FTRE) ) has released its Q4 earnings. Here is a breakdown of the information Fortrea Holdings Inc. presented to its ...

For the three months and full-year ended December 31, 2024, from continuing operations:Revenues of $697.0 million for the fourth quarter, ...

DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L. Russell, a financial and ...

Fortrea is a global, late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.

STORY HIGHLIGHTS Fortrea reaches agreement with Starboard Value LP, appoints new board member. Fortrea's stock has fallen nearly 50% since spinning off from Labcorp. Starboard may appoint ...

DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L. Russell, a financial and ...